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Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) caused by SFTS virus (SFTSV) usually have a
high fatality. At present no effective therapy or vaccine are available, so early diagnosis of SFTS is crucial to prevent
and control SFTSV infection. This study aimed to establish a national reference for these diagnostic kits of SFTSV
genome and make the diagnosis of the disease effective.
Methods: Six SFTSV strains isolated from different regions, and five relative viruses with similar clinical manifestations
were selected as positive and negative references and assessed using real time quantitative PCR (q-PCR) using specific
primers and probe and two commercial kits. The stability of the references was also assessed at 37 °C, room
temperature or -70 °C for 8 days, 14 days or 8 months respectively, or following several cycles of freezing-thawing.
Collaborative calibration of the references was performed by three labs.
Results: The references indicated good accuracy and specificity. The lowest detection limit was 102 U/mL. The
accuracy was coefficient of variation less than 5%. The references were highly stable at high temperatures and after
long storing and freezing-thawing treatment.
Conclusions: We successfully established a national reference with good accuracy, high specificity, sensitivity and stability,
which can be applied for quality control of commercial SFTSV diagnostic kits, thus preventing and controlling SFTS.
Trial registration: The references have been finished and it was retrospectively registered in the following article.
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Background
In 2007, some patients with severe fever, gastrointestinal
bleeding and thrombocytopenia syndrome were first dis-
covered in central and eastern China [1, 2], but the
pathogen cannot be determined. The pathogen respon-
sible for the syndrome was not identified until a novel
Phlebovirus (family Bunyaviridae) named Sever Fever
Thrombocytopenia Syndrome virus (SFTSV), was iso-
lated from a sample collected from a patient in Henan
Province in China at 2009 [3]. Then the cases were suc-
cessively reported in Korea and Japan [4–6].
SFTSV, like other viruses in genus Phlebovirus, is
an enveloped, segmented minus-strand RNA virus.
The genome consists of three segments: L (large), M
(middle) and S (small), which respectively encode the
RNA-dependent RNA polymerase, Gn-Gc envelope
glycoproteins, nucleocapsid and non-structural
proteins [3].
SFTSV infection is clinically characterized by fever,
thrombocytopenia and leukopenia, gastrointestinal symp-
toms, and multiorgan dysfunction. The initial case fatality
of SFTSV infection was 30% [3, 7] in China and according
to the national surveillance data, the case fatality from
2011 to 2014 was 7.9% [8].
Early clinical diagnosis of SFTSV infection is crucial
for controlling the spread of SFTS. Generally, infec-
tion is confirmed via detection of viral genome or
virus-specific antibodies in the patient’s blood or
serum [9]. Several SFTSV RNA detection kits are cur-
rently available [10–12]. However, no references are
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available for these commercial kits. In this study we
established a national reference for SFTSV RNA diag-




Six SFTSV strains (AH12, HN1, JS3, LN3, SD4, and
HB29 isolated from Anhui, Henan, Jiangsu, Shandong,
and Hubei, respectively) were provided by the Na-
tional Vaccine & Serum Institute (Beijing, China).
Japanese encephalitis virus (JEV) SA14-14-2, dengue
virus (DENV) Ban18 and yellow fever virus (YFV)
17D were provided by Arbovirus Vaccine Group, Na-
tional Institutes for Food and Drug Control (NIFDC).
Inactivated hemorrhagic fever with renal syndrome
virus (HFRSV) and tick-borne encephalitis virus
(TBEV) Senzhang strain was provided by Changchun
Institute of Biological Products Co., Ltd.
Materials
Nucleic acid detection kits for SFTSV (PCR-fluores-
cence probe techniques) were obtained from SinoMD
Gene (Beijing, China) and DaAn Gene (Guangzhou,
China). An RNA extraction QIAamp Viral RNA Mini
Kit (cat 52904) was obtained from Qiagen (Hilden,
Germany). Reverse transcriptase was purchased from
Promega (Madison, WI, USA), and La Taq was pur-
chased from Takara (Shiga, Japan).
Selection of references
Four kinds of references (positive, negative, sensitivity
and accuracy) were investigated.
Positive references
References should be broad-spectrum and representa-
tive. So the phylogenetic tree of SFTSV, based on the
S segment, was first draw using MEGA 6.0 (Fig. 1).
To represent a range of epidemic regions and disease
severities, six SFTSV strains AH12, HN1, JS3, LN3,
SD4, and HB29, isolated from Anhui, Henan, Jiangsu,
Shandong, and Hubei, respectively, were used as posi-
tive references.
Fig. 1 The phylogenetic tree of SFTSV based on S segment. The GenBank number of each virus was listed as follow, SD24 (HM802205.1), SD4
(HM802204.1), JS4 (HQ141606.1), AH12 (HQ141591), LN2 (HQ141609.1), HN6 (HQ141597.1), JS2012-tick01 (KC473542.1), LN3 (HQ141612.1), JS3
(HQ141603), HL (KF791952.1), HN13 (HQ141600.1), AH15 (HQ141594.1), HB29 (HM745932), Z37 (AF187082.1), L99 (AF288299.1), Z10 (EF533944.1),
HTV (U37768.1). Red dots indicate the strains selected for references
Table 1 q-PCR results for specificity of references
Strains Ct value
Specific primers and probe SinoMD kit DaAn kit
Exp 1 Exp 2 Exp 1 Exp 2 Exp 1 Exp 2
AH12 22.89 22.84 24.69 26.50 20.72 18.60
HN1 24.05 23.53 24.96 26.04 20.91 20.15
JS3 25.01 25.26 25.01 25.50 21.94 20.84
LN3 24.29 23.96 24.26 22.61 21.26 20.04
SD4 24.09 24.05 26.90 29.86 21.42 19.27
HB29 23.68 22.99 25.30 23.12 20.44 18.87
Positive 21.89 21.57 17.29 18.99 23.49 19.77
Negative — — — — — —
Exp experiment
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Negative references
Five arthropod-borne or blood-borne viruses (JEV
A14-14-2 strain, DENV Ban18 strain, YFV 17D
strain, HFRSV L99 strain and TBEV Senzhang
strain), which cause similar clinical manifestations to
SFTSV infection, including fever, headache, disturb-
ance of consciousness, convulsions, bleeding and
kidney damage, meningeal irritation and paralysis,
were selected as negative references to evaluate the
kit specify [18–22].
The earliest isolated and extensively investigated SFTSV
strain HB29 was used as references for sensitivity and
accuracy.
Preparation of the references
Six SFTSV strains AH12, HN1, JS3, LN3, SD4, and
HB29 were amplified. Virus titers were determined be-
fore inactivation using the cytopathogenic effect assay
(CPE). JEV A14-14-2 strain, DENV Ban18 strain and
YFV 17D strain was amplified in BHK 21 cells, and the
Fig. 2 q-PCR reaction curve of positive references (a) and negative references (b)
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titers were determined using a CPE method. HFRSV L99
strain and TBEV Senzhang strain were provided by
Changchun Institute of Biological Products. All viruses
were inactivated using formaldehyde (1:1000) at 37 °C
for 24 h and stored in −80 °C for use.
Confirmation of the references
Sequence confirmation of the references
The S gene represents a conserved region of the SFTSV
genome [3]. The whole genome of JEV is conserved [23].
The NS1 gene represents a conserved region of DENV
[24]. The S gene represents a conserved region of HFRSV
[25]. 3′ UTR is the conserved region of YFV [21]. 5′UTR
is the conserved region of TBEV [22]. The specific primers
for the conserved region of each virus were designed using
DNAMan (Lynnon, San Ramon, CA, USA).
Virus RNA genome was extracted using QIAamp Viral
RNA Mini Kit and then reverse transcribed into cDNA.
The cDNA was used as template for PCR in a total vol-
ume of 50 μL (LA Taq, 0.2 μL, Buffer 5 μL, dNTP 4 μL,
cDNA template 2 μL, primers 2 μL and ddH2O 37 μL)
using the following procedures: denaturation at 94 °C for
2 min; 30 cycles of 94 °C for 30 s, 56 °C for 30 s, 72 °C for
30 s, and finally extension at 72 °C for 5 min. The PCR
products were confirmed by sequencing (Invitrogen,
Carlsbad, CA, USA).
Confirmation by quantitative PCR (q-PCR)






References were quantified using specific primers and
probes, SFTSV nucleic acid detection kits (PCR-fluores-
cence probe techniques) from SinoMD Gene, and DaAn
Gene. The reaction system for specific primers and probes
were: 0.1 μL LA Taq, 2.5 μL reaction buffer, 2 μL dNTP,
5 μL template, 2 μL primes, 1 μL probe, and 12.4 μL
ddH2O. The q-PCR procedure was as follows: denatur-
ation at 94 °C for 10 min; 40 cycles of 94 °C for 30s, 56 °C
for 30s. The reaction system for the SinoMD kit was:
SFTSV PCR buffer 12.5 μL, SFTSV primers and probe
mixture 2.5 μL, SFTSV internal template 1.0 μL, DEPC
H2O 4.0 μL, template 5.0 μL. The q-PCR procedure was
as follows: 45 °C for 15 min, 94 °C for 5 min; 40 cycles of
94 °C for 15 s, 60 °C for 35 s; 25 °C for 1 min. The reaction
system for the DaAn kit was: SFTSV reaction buffer A
17 μL, SFTSV reaction buffer B 3 μL, template, 5 μL. The
q-PCR procedure was as follows: 50 °C for 15 min, 94 °C
for 15 min; 45 cycles of 94 °C for 15 s, 55 °C for 45 s.
Confirmation of sensitivity
The extensively investigated SFTSV strain HB29 was
used as a reference for sensitivity testing. First, the re-
combinant plasmid containing the conserved S gene
pMD18-TS was constructed, serial diluted 1:10 and then
used to establish a standard curve. 4.83 × 106copies/mL
of SFTSV HB29 was defined as 106 U/mL. Ten-fold ser-
ial dilutions of SFTSV HB29 (105 U/mL, 104 U/mL, 103
U/mL, 102 U/mL, 10 U/mL) were used as sensitivity ref-
erences and labeled S1-S5. The lowest detection limit of
the reference was assessed using SinoMD kit and DaAn
kit for 4 times.
Confirmation of accuracy
The reference (104 U/mL (S3) SFTSV HB29) was de-
tected using the SinoMD and DaAn kits for 10 times
and the coefficient of variation (CV) of each Ct was cal-
culated and defined as the accuracy of the reference.
Stability of the references
Three sets of references stored at −70 °C were randomly
selected. One set was placed at 37 °C with 60–80% rela-
tive humidity for 8 days, one at room temperature with
20–50% relative humidity for 14 days, and one at −70 °C
for 8 months. The stability of these references was deter-
mined using the detection kits.
The references stored at −70 °C were subjected to 3 cy-
cles of freeze-thaw, then nucleic acid detection was per-
formed to determine the effect of freeze-thaw treatment.
Collaborative calibration of the references
According to the Program, Protocol, Standard Operating
Procedure of Collaborative Calibration approved by the
National Administrative Committee for Certified Refer-
ence Materials, and unified original experimental record,
the collaborative calibration was completed by the Sec-
ond Group for in vitro Diagnostics of NIFDC, Arbovirus
Vaccine Group of NIFDC and DaAn Gene Co. Ltd.
Table 2 q-PCR results for sensitivity of reference
HB29 strain Ct value
SinoMD kit DaAn kit
Exp 1 Exp 2 Exp 3 Exp 4 Exp 1 Exp 2 Exp 3 Exp 4
S1 (105 U/mL) 30.03 27.35 29.40 30.23 21.42 22.48 26.37 24.11
S2 (104 U/mL) 32.21 33.16 32.74 33.27 26.05 24.84 28.86 26.69
S3 (103 U/mL) 37.07 34.04 35.60 36.19 28.28 28.32 30.75 28.13
S4 (102 U/mL) — 37.36 — — 32.20 29.46 31.79 31.08
S5 (10 U/mL) — — — — — 32.37 32.06 31.17
Positive 17.59 16.75 17.84 19.07 19.77 23.49 20.69 20.00
Negative — — — — — — — —
Exp experiment
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Statistical analysis
Statistical analysis was performed using SAS 9.1 (Raleigh,
NC, USA), and means are presented. T test was used
to analyze the stability in each treatment groups. A
p value < 0.05 was considered to indicate statistical
significance.
Results
Preparation of the references
Using the CPE method, the titer of SFTSV ranged from
6.8 to 8.3 lg CCID50/mL, the titers of the JEV A14-14-2
strain, DV Ban18 strain and YFV 17D strain were 5.56 lg
PFU/mL, 5.40 lg PFU/mL and 6.09 l g PFU/mL, respect-
ively. The titers of the provided HFRSV L99 strain and
TBEV Senzhang strain were 7.3 lg CCID50/mL and 8.0 lg
LD50/mL, respectively.
Specificity of the references
Sequencing of these 6 positive and 5 negative refer-
ences indicated that all conserved virus genes or
genomes (S gene of SFTSV, whole genome of JEV,
NS1 gene of, S gene of HFRSV, 3′ UTR of YFV and
Fig. 3 q-PCR reaction curve of sensitivity reference using SinoMD kit (a) and DaAn kit (b)
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5′UTR of TBEV) shared 99% homology with genes
from the same or similar virus strains.
Next these positive and negative references were ap-
plied for q-PCR using SFTSV specific primers and
probes, and kits from SinoMD and DaAn gene. The
positive Ct value was defined as less than 35 for spe-
cific primers and probes, and less than 37 for the two
kits according to the manufacturers’ protocol. The Ct
values of 6 positive references were all less than 35,
with typical S curves for specific primers and probes
as well as two commercial kits (Table 1, Fig. 2a). No
typical S curve was observed in five negative samples
(Fig. 2b), so no Ct values were given. Our results in-
dicated that these positive and negative references
were highly specific and accurate.
Sensitivity of the references
The recombinant plasmid pMD18-TS for standard
curve ranged from 2.01 × 1012 copies/mL to 2.01 × 104
copies/mL in ten-fold dilutions. The sensitivity refer-
ence SFTSV HB29 strain was used at 4.83 × 106 cop-
ies/mL, serially diluted 1:10 five types (S1-S5), and
detected using two commercial kits. As shown in
Table 2, the detection limit of the SinoMD kit was S3
with 103 U/mL virus, while the detection limit of the
DaAn kit was S4 with 102 U/mL virus. Although S5
with 10 U/mL virus can be detected using the DaAn
kit in 3 of 4 times, the Ct value and dilution did not
have a linear relationship. The detection limit was
still S4 with 102 U/mL virus. The q-PCR reaction
curves of sensitivity reference are shown in (Fig. 3a
and 3b).
The virus titer in the serum of patients with SFTSV
infection is reported to usually range between 102 and
108 copies/mL [26–29], so to be clinically useful a refer-
ence concentration of 102 U/mL must be detectable by
commercial kits.
Table 3 q-PCR results for accuracy of reference
References Ct value
SinoMD kit DaAn kit
Exp 1 Exp 2 Exp 1 Exp 2
R1 33.27 33.80 26.05 27.47
R2 34.19 34.98 27.63 27.08
R3 30.72 33.10 27.67 26.22
R4 31.24 33.03 27.38 28.15
R5 32.75 36.36 26.26 27.12
R6 32.19 34.00 26.14 25.56
R7 31.85 33.34 26.11 25.67
R8 32.62 33.93 25.29 24.84
R9 34.43 32.74 27.34 28.03
R10 30.90 34.18 26.89 25.09
SD 1.29 1.07 0.81 1.21
Average 32.42 33.95 26.68 26.52
CV (%) 3.98 3.16 3.05 4.55
Exp experiment, R1-R10 repeat 1-10, SD standard deviation, CV coefficient of variation
Fig. 4 q-PCR reaction curve of accuracy for reference
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Repeatability of the references
To evaluate the repeatability of the accuracy refer-
ence, a sample containing 104 U/mL (S3) SFTSV
HB29 was detected using the SinoMD and DaAn kits
in five independent experiments including two dupli-
cates each. As shown in Table 3, the SinoMD kit CV
of Ct was 3.98 and 3.16%, while the DaAn kit CV of
Ct was 3.04 and 4.55%. So the CV of Ct for this ac-
curacy reference was determined as less than 5%. See
(Fig. 4) for q-PCR reaction curve of accuracy for
reference.
Stability of all references
The appearance of the references was not altered by
storage at 37 °C for 8 days, and at room temperature
with 20–50% for 14 days, or at −70 °C for 8 months.
All references appeared to be transparent liquids with
no turbidity or precipitation. When these references
were subjected to q-PCR with specific primers,
treated positive references were positive, while all
treated negative references were negative, without
typical S curves or Ct values higher than 37. The de-
tection limits of all treated sensitivity references were
102 U/mL virus and the CV values of Ct for all
treated accuracy references were less than 5% (Table 4,
Fig. 5a, 5b and 5c).
The references were subjected to 3 cycles of freeze-
thaw treatment and after each cycle tested using q-PCR.
The accuracy reference CV values of Ct did not differ
between the three cycles (Tables 5, P > 0.05). All these
data suggest that all references exhibit good stability to
temperature.
Calibration of the references
Calibration of the references is described in Table 6. In
three independent laboratories the positive rate of
positive references and negative rate of negative refer-
ences were all 100%. The detection limit of the sensi-
tivity reference was 102 U/mL. The CV of the
accuracy reference ranged from 0.45 to 4.55%, which
were all less than 5%.
Table 4 q-PCR results for stability of reference in different storage conditions
References Ct value Normal value
37 °C for 8 days Room temperature for 14 days −70 °C for 8 months
Positive P1 (AH12) 18.02 22.81 22.84 18.60
P2 (HN1) 18.49 24.02 23.53 20.15
P3 (JS3) 24.83 25.07 25.26 20.84
P4 (LN3) 18.80 24.52 23.96 20.04
P5 (SD4) 22.41 23.88 24.05 19.27
P6 (HB29) 17.92 22.35 22.99 18.87
Sensitivity S1 (105U) 20.20 26.69 25.51 21.42
S2 (104U) 23.99 30.03 27.46 26.05
S3 (103U) 27.40 32.23 30.78 28.28
S4 (102U) 35.29 35.54 31.08 32.20
S5 (10U) — 37.23 32.68 —
Accuracy R1 27.50 29.87 27.77 27.47
R2 24.56 29.78 28.08 27.08
R3 27.50 29.21 27.89 26.22
R4 24.30 30.61 27.89 28.15
R5 24.27 30.04 27.63 27.12
R6 23.99 28.70 27.85 25.56
R7 25.09 30.03 27.81 25.67
R8 25.11 31.76 28.01 24.84
R9 25.01 31.39 27.60 28.03
R10 25.06 31.16 27.37 25.09
SD 1.26 0.97 0.21 1.21
Average 25.24 30.26 27.79 26.52
CV 5.00% 3.20% 0.75% 4.55%
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Discussion
SFTS caused by SFTSV infection was first emerged
in China in 2009 [3], followed by reports from other
Asian countries. At present no effective therapies or
vaccines are available, and SFTS is associated with
high rates of fatality [1, 5, 30]. In addition to redu-
cing rates of tick bite, early diagnosis and treatment
are important. Hence many research institutes and
companies are developing diagnostic kit for SFTSV
based on the detection of virus genome using q-PCR.
However, no references are yet available to control
the quantity of these kits. Thus in this study we
established national references that allow specific,
sensitive and accurate detection of the SFTSV
genome.
When establishing reference standards, the references
should be represent a broad-spectrum of relevant viruses
[31]. In 2007, the first SFTS case in China was reported
in Henan Province, and since cases have been reported
in Shandong, Hubei, Anhui, Jiangsu, and Niaoning [1].
Thus we chose viruses from these regions to use as the
reference strains. The severity of the disease caused by
these virus strains also should be considered. We drew a
phylogenetic tree based on S segment and selected six
representative SFTSV strains, AH12, HN1, JS3, LN3,
SD4, and HB29, isolated from Anhui, Henan, Jiangsu,
Liaoning, Shandong, Hubei respectively, as positive
references. When selecting negative references, HFRSV
was chosen because of the similar structure and family to
SFTSV [32]. JEV, DenV, YFV and TBEV were chosen as
they cause similar clinical symptoms and are transmitted
by arthropods or blood, like SFTSV [18–22]. Before estab-
lishing references, conserved regions of these 11 viruses
were amplified using specific primers and sequenced.
Then q-PCR was used to detect the specificity and
accuracy of positive and negative references.
When selecting sensitive and accurate references, the
earliest identified and extensively studied HB29 strain
was chosen. The serial dilution method was used to de-
termine the detection limit of the reference. Through
collaborative calibration by three labs, the detection limit
was set as 102 U/mL, as SFTSV infection is reported to
cause titers of 102-108copies/mL in the serum [26–29].
The CVs of Ct were all less than 5%, indicating accept-
able accuracy.
We also investigated the capacity of the references
to withstand freeze-thaw and conditions typical of
storage, transportation and application, as previously
reported [33]. Storage at room temperature, 37 °C
and several freeze-thaw cycles did not alter the specificity,
accuracy, and sensitivity of the references, indicating
high stability.
Fig. 5 q-PCR results for stability of the references under
different treatments. a Positive references; b Sensitivity
references; c Accuracy references
Table 5 q-PCR results for stability of the references subjected to
freeze-thraw
Reference Ct value
First F-T Second F-T Third F-T
HB29 strain 25.49 26.23 27.31
26.29 25.80 26.58
26.10 26.28 25.80
Average 25.96 26.10 26.56




Average 32.36 32.35 32.95
F-T freeze-thaw
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Conclusions
The national reference had been established successfully
and proved good accuracy, high specificity, sensitivity
and stability. It means that the reference will be widely
used in the quality control of the similar commercial
SFTSV diagnostic kits and guarantee their effectiveness,
thus more SFTSV infection can be diagnosed rapidly
and the targeted prevention and control measures will
be developed.
Additional file
Additional file 1: The q-PCR results and phylogenetic tree of SFTSV
study. (RAR 2243 kb)
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